Proniras Corporation

📍 Seattle, United States🗓 Founded 2018👥 2 employees💰 Last funded 2017
Biotechnology🌐 proniras.com
Website LinkedIn
Proniras Corporation is a preclinical-stage biotech company focused on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury that occurs following exposure to organophosphorus nerve agents.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Proniras Corporation?
Proniras Corporation has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Proniras Corporation last raise funding?
The most recent investment in Proniras Corporation recorded on gritt.io was in 2017.
When was Proniras Corporation founded?
Proniras Corporation was founded in 2018.
What industry is Proniras Corporation in?
Proniras Corporation operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Proniras Corporation based?
Proniras Corporation is headquartered in Seattle, United States.